210992-28-2Relevant articles and documents
3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists
Tehrani, Lida R.,Smith, Nicholas D.,Huang, Dehua,Poon, Steve F.,Roppe, Jeffrey R.,Seiders, Thomas Jon,Chapman, Deborah F.,Chung, Janice,Cramer, Merryl,Cosford, Nicholas D.P.
, p. 5061 - 5064 (2007/10/03)
Structure-activity relationship studies on the phenyl ring of 3-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile 2 led to the discovery that small, non-hydrogen bond donor substituents at the 3-position led to a substantial increase in in vitro potency. In particular, 3-fluoro-5-(5-pyridin- 2-yl-2H-tetrazol-2-yl)benzonitrile (7) is a highly potent and selective mGlu5 receptor antagonist with good rat pharmacokinetics, brain penetration, and in vivo receptor occupancy.
5-FLUORO-, CHLORO- AND CYANO-PYRIDIN-2-YL-TETRAZOLES AS LIGANDS OF THE METABOTROPIC GLUTAMATE RECEPTOR-5
-
Page/Page column 22, (2008/06/13)
The present invention relates to new compounds of formula I, wherein Z, Q, X1, X2, R1 and R2, are as defined as in formula I, or salts, solvates or solvated salts thereof, processes for their preparation, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity
Roppe, Jeffrey,Smith, Nicholas D.,Huang, Dehua,Tehrani, Lida,Wang, Bowei,Anderson, Jeffrey,Brodkin, Jesse,Chung, Janice,Jiang, Xiaohui,King, Christopher,Munoz, Benito,Varney, Mark A.,Prasit, Petpiboon,Cosford, Nicholas D. P.
, p. 4645 - 4648 (2007/10/03)
The highly potent, selective, and brain-penetrant metabotropic glutamate subtype 5 (mGlu5) receptor antagonists 3-(5-pyridin-2-yl-2H-tetrazol-2-yl) benzonitrile (47) and 3-fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile (48) are reported. Compound 47 is active in the rat fear-potentiated startle (FPS) model of anxiety with ED50 = 5.4 mg/kg (po) when dosed acutely. In this model the anxiolytic effects of 47 rapidly tolerate on repeated dosing.